Starbucks Corporation Jumps After Solid Earnings (SBUX, SKUL, NEE, INHX)

Skullcandy Inc  (NASDAQ:SKUL) shares soared 12.10% in the pre-market session after the company said that it earned 17 cents a share on revenue of $60.6 million in its third quarter, ahead of analysts’ estimates of 14 cents a share on revenue of $50.60 million.

For the FY2011, the company projects to earn 93 cents a share on revenue of $231 million, topping analysts’ estimates of 90 cents a share on revenue of $217.3 million.

Starbucks Corporation  (NASDAQ:SBUX) added 3.36% to $41.41 on high volume after the company posted a 28% jump in fiscal-fourth quarter profit on continued strong sales at existing stores. For the fourth quarter, the company earned $358.5 million, or $0.47 a share, from $278.9 million, or $0.37 a share, in the same period last year, beating Wall Street’s forecast by $0.06 a share.

NextEra Energy, Inc.  (NYSE:NEE)   reported earnings of $1.31 a share on revenue of $4.38 billion in its third quarter, missing analysts estimates of $1.41 a share on revenue of $4.44 billion.

Inhibitex, Inc.  (NASDAQ:INHX)  soared 127.27% to $9 in the pre-market session after the company announced its financial results for the third quarter ended September 30, 2011 and provided an update on several recent corporate developments, including top-line safety and antiviral data from the first cohort in its ongoing clinical trial designed to evaluate higher doses of INX-189, an oral nucleotide polymerase inhibitor, being developed to treat chronic infections caused by hepatitis C virus (HCV), administered as monotherapy or in combination with ribavirin for seven days.


The assembled information distributed by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented herein. will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.

Our Research Report on SBUX is now available. Don´t Trade SBUX until you Read our FREE FULL REPORT. Click Here